Abstract
The transmembrane helical bundle of G protein-coupled receptors (GPCRs) dimerize through helix-helix interactions in response to inflammatory stimulation. A strategy was developed to target the helical dimerization site of GPCRs by peptidomimetics with drug like properties. The concept was demonstrated by selecting a potent backbone cyclic helix mimetic from a library that derived from the dimerization region of chemokine (C-C motif) receptor 2 (CCR2) that is a key player in Multiple Sclerosis. We showed that CCR2 based backbone cyclic peptide having a stable helix structure inhibits specific CCR2-mediated chemotactic migration
Original language | English |
---|---|
Pages (from-to) | 3958-3966 |
Number of pages | 9 |
Journal | Bioorganic and Medicinal Chemistry |
Volume | 21 |
Issue number | 13 |
DOIs | |
State | Published - 1 Jul 2013 |
Keywords
- Backbone cyclization
- G protein-coupled receptors
- GPCR dimerization
- Helix mimetics
- Multiple Sclerosis
- Urea cyclization
All Science Journal Classification (ASJC) codes
- Biochemistry
- Molecular Medicine
- Molecular Biology
- Pharmaceutical Science
- Drug Discovery
- Clinical Biochemistry
- Organic Chemistry